Search

Your search keyword '"Tong, Zhaohui"' showing total 698 results
Start Over Author "Tong, Zhaohui"
698 results on '"Tong, Zhaohui"'

13. A multicentre, randomised, double-blind, double-dummy, parallel-controlled, phase 3 clinical trial assessing the efficacy and safety of intravenous nemonoxacin malate vs. levofloxacin for community-acquired pneumonia in adult patients

Author

LI, Ying, Zhu, Demei, Sun, Shenghua, Chang, Xiaoyue, Cao, Zhaolong, Yang, Yanping, Fu, Xiuhua, Li, Xiangyang, Xu, Jinfu, Zhu, Yingqun, Hui, Fuxin, Xu, Xingxiang, Chen, Zhang, Peng, Liping, Ma, Zhuang, Mo, Biwen, Li, Chen, Lv, Yuan, Zhao, Li, Zhu, Guangfa, He, Yong, Liu, Hua, Chen, Jichao, Wang, Ying, Liang, Yongjie, Lu, Youjin, Qin, Zhiqiang, Yang, Hongzhong, Zhang, Min, Wu, Shiman, Tong, Zhaohui, Ye, Feng, Xiao, Zuke, Wang, Xuefen, Qiu, Chen, Kuang, Jiulong, Huang, Huaping, Wang, Kai, Ying, Kejing, Jin, Faguang, Lv, Xiaoju, Huang, Yijiang, Liu, Deling, Wang, Wei, and Zhang, Yingyuan

Published
2024
Full Text
View/download PDF

38. Figure S7 from Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer

Author

Shi, Qi, primary, Xu, Guixuan, primary, Jiang, Yuliang, primary, Yang, Ju, primary, Han, Xueping, primary, Wang, Qian, primary, Li, Ya, primary, Zhang, Zhiyu, primary, Wang, Kaige, primary, Peng, Hao, primary, Chen, Fangfang, primary, Ma, Yandi, primary, Zhao, Linyue, primary, Chen, Yunzhao, primary, Liu, Zheng, primary, Yang, Lan, primary, Jia, Xingyuan, primary, Wen, Tao, primary, Tong, Zhaohui, primary, Cui, Xiaobin, primary, and Li, Feng, primary

Published
2024
Full Text
View/download PDF

39. Supplementary Data from Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer

Author

Shi, Qi, primary, Xu, Guixuan, primary, Jiang, Yuliang, primary, Yang, Ju, primary, Han, Xueping, primary, Wang, Qian, primary, Li, Ya, primary, Zhang, Zhiyu, primary, Wang, Kaige, primary, Peng, Hao, primary, Chen, Fangfang, primary, Ma, Yandi, primary, Zhao, Linyue, primary, Chen, Yunzhao, primary, Liu, Zheng, primary, Yang, Lan, primary, Jia, Xingyuan, primary, Wen, Tao, primary, Tong, Zhaohui, primary, Cui, Xiaobin, primary, and Li, Feng, primary

Published
2024
Full Text
View/download PDF

40. Data from Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer

Author

Shi, Qi, primary, Xu, Guixuan, primary, Jiang, Yuliang, primary, Yang, Ju, primary, Han, Xueping, primary, Wang, Qian, primary, Li, Ya, primary, Zhang, Zhiyu, primary, Wang, Kaige, primary, Peng, Hao, primary, Chen, Fangfang, primary, Ma, Yandi, primary, Zhao, Linyue, primary, Chen, Yunzhao, primary, Liu, Zheng, primary, Yang, Lan, primary, Jia, Xingyuan, primary, Wen, Tao, primary, Tong, Zhaohui, primary, Cui, Xiaobin, primary, and Li, Feng, primary

Published
2024
Full Text
View/download PDF

49. Clinical Characteristics and Prognostic Predictors of Pneumocystis Jirovecii Pneumonia in Patients with and without Chronic Pulmonary Disease: A Retrospective Cohort Study.

Author

Feng, Qiuyue and Tong, Zhaohui

Subjects
PNEUMOCYSTIS pneumonia, LUNG diseases, PROGNOSTIC models, CHRONIC diseases, MORTALITY risk factors
Abstract

Pneumocystis jirovecii pneumonia (PJP) is a severe respiratory infection caused by Pneumocystis jirovecii in immunocompromised hosts. The role of P. jirovecii colonization in the development or progression of various pulmonary diseases has been reported. Our aim was to explore serial change in serum biomarkers and the independent risk factors for mortality in patients with and without chronic pulmonary diseases who developed PJP. Methods: We performed a retrospective study to select patients with Pneumocystis jirovecii pneumonia between January 1, 2012, and December 31, 2021. Information regarding demographics, clinical characteristics, underlying diseases, laboratory tests, treatment, and outcomes was collected. Univariate and multivariate logistic regression analyses were used to identify independent predictors of in-hospital mortality. Results: A total of 167 patients diagnosed with PJP were included in the study: 53 in the CPD-PJP group and 114 in the NCPD-PJP group. The number of patients with PJP showed an increasing trend over the 10-year period. A similar trend was observed for in-hospital mortality. Independent risk factors associated with death in the NCPD-PJP group were procalcitonin level (adjusted OR 1.08, 95% CI 1.01– 1.16, P=0.01), pneumothorax (adjusted OR 0.07, 95% CI 0.01– 0.38, P=0.002), neutrophil count (adjusted OR 1.27, 95% CI 1.05– 1.53, P=0.01) at 14 days, and hemoglobin level (adjusted OR 0.94, 95% CI 0.91– 0.98; P=0.002) at 14 days after admission. The risk factor associated with death in the CPD-PJP group was neutrophil count (adjusted OR 1.19, 95% CI 0.99– 1.43; P=0.05) at 14 days after admission. Conclusion: The risk factors for death were different between patients with PJP with and without chronic pulmonary disease. Early identification of these factors in patients with PJP and other underlying diseases may improve prognosis. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results